INDOCONSEIndoco Remedies Limited· PharmaceuticalsHighNegative
Announced Fri, 15 May · 12:20 IST

Indoco Remedies Limited has informed the Exchange regarding Demise of Mr Anand Nadkarni , Non- Executive Director of the company on May 15, 2026.

Management Changes View source PDF

INDOCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹224.90
prior close
₹227.88
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.5-0.3-1.1-4.4-5.1-6.4-8.9-11.1-14.6-11.8+6.6+11.0
Up moveDown movePending
AI summary

Indoco Remedies Limited announced the death of Dr. Anand Nadkarni, Non-Executive Director (DIN: 06881461), on May 15, 2026. The company described his association as a director as having immensely benefited the company. The death was sudden and unexpected, with the company stating it will be an irreparable loss. The intimation was made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dr. Nadkarni served as a Non-Executive Director and his cessation date is recorded as May 15, 2026.

Likely market impact

The unexpected passing of a Non-Executive Director represents a loss of board experience and may have a minor negative sentiment impact on the stock in the short term, as investors often react cautiously to leadership changes, even when non-executive.